Literature DB >> 7359190

The effect of phenobarbital on the toxicity and tumoricidal activity of CCNU in a murine brain tumor model.

P J Muller, C H Tator, M Bloom.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 7359190     DOI： 10.3171/jns.1980.52.3.0359

Source DB:  PubMed          Journal:  J Neurosurg        ISSN： 0022-3085            Impact factor:   5.115


× No keyword cloud information.
  7 in total

1.  Toca 511 plus 5-fluorocytosine in combination with lomustine shows chemotoxic and immunotherapeutic activity with no additive toxicity in rodent glioblastoma models.

Authors:  Kader Yagiz; Tiffany T Huang; Fernando Lopez Espinoza; Daniel Mendoza; Carlos E Ibañez; Harry E Gruber; Douglas J Jolly; Joan M Robbins
Journal:  Neuro Oncol       Date:  2016-05-10       Impact factor: 12.300

2.  Intracarotid infusion of ACNU and BCNU as adjuvant therapy of malignant gliomas. Clinical aspects and critical considerations.

Authors:  L Papavero; F Loew; H Jaksche
Journal:  Acta Neurochir (Wien)       Date:  1987       Impact factor: 2.216

Review 3.  Medical management of patients with brain tumors.

Authors:  Patrick Y Wen; David Schiff; Santosh Kesari; Jan Drappatz; Debra C Gigas; Lisa Doherty
Journal:  J Neurooncol       Date:  2006-06-29       Impact factor: 4.130

4.  Focal radiation therapy of brain metastases after complete surgical resection.

Authors:  Gautam Bahl; Greg White; John Alksne; Lakshmi Vemuri; Matthew A Spear
Journal:  Med Oncol       Date:  2006       Impact factor: 3.064

5.  Treatment of malignant brain tumours with ACNU and phenobarbital: continuous infusion of ACNU into internal carotid artery and systemic administration of phenobarbital.

Authors:  K Yumitori; H Handa; T Teraura; J Yamashita
Journal:  Acta Neurochir (Wien)       Date:  1984       Impact factor: 2.216

6.  Studies on the mechanism of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU)-induced hepatotoxicity. II. Biochemical and morphological characterization of the injury and its prevention by phenobarbital.

Authors:  A E Ahmed; M Grissom; R el-Azhary; A Haque; P J Boor; J Costanzi
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

7.  Clinical pharmacokinetics of oral CCNU (lomustine).

Authors:  F Y Lee; P Workman; J T Roberts; N M Bleehen
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.